Determination of free therapeutic vedolizumab
Vedolizumab is a recombinant protein used to treat Crohn’s disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples. Not all patients respond equally to vedolizumab, and this test helps to stratify patients according to whether they are likely to benefit from treatment or not, allowing clinicians to evaluate the drug efficacy and investigate primary non-response, loss of response and non-remission.
Please contact us for your nearest test reference laboratory.
